Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 21 | Dec' 20 | Sep' 20 | Jun' 20 | Mar' 20 | |
|---|---|---|---|---|---|
| Sales | 137.58 | 168.46 | 137.55 | 155.96 | 113.64 |
| Operating profit | 26.78 | 34.88 | 23.05 | 29.00 | 18.39 |
| Interest | 2.14 | 1.10 | 1.32 | 0.79 | 1.67 |
| Gross profit | 36.55 | 40.03 | 34.68 | 28.26 | 16.63 |
| EPS (Rs) | 0.58 | 0.71 | 0.57 | 0.54 | 0.18 |
Quarterly
results in details
| Mar' 21 | Dec' 20 | Sep' 20 | Jun' 20 | Mar' 20 | |
|---|---|---|---|---|---|
| Other income | 11.91 | 6.24 | 12.96 | 0.05 | -0.08 |
| Stock adjustment | -4.60 | 5.08 | -0.36 | 0.43 | -8.21 |
| Raw material | 74.49 | 77.25 | 70.95 | 66.34 | 57.41 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 15.67 | 13.83 | 12.86 | 12.27 | 12.34 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 25.24 | 37.42 | 31.05 | 47.91 | 33.70 |
| Provisions made | - | - | - | - | - |
| Depreciation | 4.15 | 4.03 | 3.67 | 3.34 | 3.46 |
| Taxation | 8.72 | 6.89 | 7.48 | 2.87 | 5.76 |
| Net profit / loss | 23.69 | 29.10 | 23.53 | 22.06 | 7.41 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 40.93 | 40.93 | 40.93 | 40.93 | 40.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 19.46 | 20.71 | 16.76 | 18.60 | 16.18 |
| GPM (%) | 24.45 | 22.91 | 23.04 | 18.12 | 14.65 |
| NPM (%) | 15.85 | 16.66 | 15.64 | 14.14 | 6.53 |
Mutual Fund Selector
Find the fund that is right for you
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis